Overall, she said, the campaign is part of Abbott’s work to “chip away” at the obstacles facing people with diabetes as they seek out proper care and treatment. It builds on the stigma ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

Above the Bias, Abbott’s minute-long spot, seeks to address the shame, guilt and misconceptions that often surround diabetes. The short film also delves into how this bias can deter patients from ...

In a report released today, Lee Hambright from Bernstein downgraded Tandem Diabetes Care (TNDM – Research Report) to a Hold, with a price ...

Medtronic ( MDT -0.99%) and Abbott Laboratories ( ABT -1.91%) are two such examples in the healthcare industry. Both are ...

As for earnings, ABT’s fourth-quarter fiscal 2024 earnings report showed sales growth of 9.5% for the year (excluding COVID ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) yesterday and set a price ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Abbott Laboratories. If we consider the ...

Abbott's ABT diversified business portfolio is well-positioned to drive momentum. However, the international business ...

DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% ...

Abbott Diabetes Care was created in 2004 with the acquisition of TheraSense Inc., a leading blood glucose monitoring business. The diagnostics portfolio was expanded with the addition of i-STAT ...

Analysts have recently evaluated Abbott Laboratories and provided 12-month price targets. The average target is $145.12, ...